Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
02 janv. 2025 16h15 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
30 déc. 2024 08h15 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
16 déc. 2024 08h30 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
04 déc. 2024 16h15 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Appoints Guy Guglielmino as Chief Commercial Officer
02 déc. 2024 16h15 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Participation at Stifel 2024 Healthcare Conference
18 nov. 2024 16h46 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
05 nov. 2024 16h05 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Participation in the UBS Global Healthcare Conference
04 nov. 2024 17h29 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
04 nov. 2024 08h00 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
04 nov. 2024 07h00 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...